Altimmune, Inc. (ALT) vs CorMedix Inc. (CRMD)
A side-by-side comparison of Altimmune, Inc. and CorMedix Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALT
Altimmune, Inc.
$2.67HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CRMD
CorMedix Inc.
$7.26HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ALT vs CRMD
growth of $100 · dividends reinvested · last 9yALT -98.0% (-35.2%/yr)CRMD +245.7% (+14.8%/yr)CRMD compounded faster over this window
Log scale — wide-divergence pair
ALT CRMD
ALT vs CRMD: by the numbers
- •CRMD is the larger company ($570M vs $519M market cap).
- •CRMD is profitable (40.49% net margin) while ALT runs a net loss (-296000.00%).
- •CRMD grew revenue faster over the past five years (352.03% vs -65.38% CAGR).
Metrics side by side
Valuation
| Metric | ALT | CRMD |
|---|---|---|
| P/E ratio | N/A | 3.41 |
| Forward P/E | N/A | 14.67 |
| P/S ratio | 16749.86 | 1.23 |
| P/B ratio | 1.09 | 1.24 |
| EV / EBITDA | N/A | 1.82 |
| FCF yield | N/A | 43.94% |
Profitability
| Metric | ALT | CRMD |
|---|---|---|
| Gross margin | 100.00% | 82.78% |
| Operating margin | -230460.98% | 46.95% |
| Net margin | -296000.00% | 40.49% |
| ROE | -19.35% | 40.62% |
| ROIC | -19.47% | 27.87% |
Growth (annualized)
| Metric | ALT | CRMD |
|---|---|---|
| Revenue CAGR (5Y) | -65.38% | 352.03% |
| Total return CAGR (5Y) | -25.30% | 9.70% |
Frequently asked
- Which has grown faster, ALT or CRMD?
- Over the past five years, CRMD grew revenue faster — ALT at a -65.38% CAGR versus CRMD at 352.03%.
- Is ALT or CRMD more profitable?
- CRMD runs the higher net margin — ALT at -296000.00% versus CRMD at 40.49%.
- How have ALT and CRMD total returns compared?
- Over the past 5 years, ALT delivered -25.30% and CRMD delivered 9.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CorMedix P/E ratioAltimmune ROECorMedix ROEAltimmune operating marginCorMedix operating marginAltimmune revenue growthCorMedix revenue growthAltimmune free cash flowCorMedix free cash flow
Altimmune & CorMedix appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.